منابع مشابه
Balancing commercial and public interests
Alarge number of randomized clinical trials with important health outcomes are completed each year. Those with favorable findings are typically reported and published rapidly, while the publication of those with unfavorable results is often delayed or given a positive "spin." This observation applies primarily to industry-sponsored trials. Our objectives are to discuss the responsibility of pha...
متن کاملPatenting human pluripotent cells: balancing commercial, academic and ethical interests.
The article addresses the issue of the ethics of patenting in human embryonic stem (hES) cells. The current stance of the European Patent Office in citing moral objections to patents on hES cells and the monopolistic scope of the Wisconsin Research Alumni Fund/Geron patents granted by the United States Patent and Trademark Office represent twin obstacles to achieving an ethical balance in paten...
متن کاملScientific basics and commercial interests in sport information technology
Betrachtet man die aktuellen Arbeitsfelder der Sportinformatik unter dem Gesichtspunkt der wissenschaftlichen Beiträge und Veröffentlichungen in Deutschland, so zeigen sich hier klare Schwerpunkte. Die größte Zahl von Arbeiten konzentriert sich auf das Gebiet von „Multimedia“ gefolgt von Modellbildung und Datenbanken. Völlig zu Recht hat damit die Sportinformatik sich auf ein zur Zeit sehr aktu...
متن کاملTransparency and e-Voting: Democratic vs. Commercial Interests
Electronic voting systems are being introduced, and have been introduced, in many countries for a variety of reasons. The introduction of computers into the electoral process can offer several advantages. Among other things it can speed up the process of calculating results, can help voters avoid accidentally spoiling their vote, and can allow voters with special needs to vote in private. Often...
متن کاملThe role of civil society in protecting public health over commercial interests: lessons from Thailand.
In October, 2002, two Thai people with HIV-1 won an important legal case to increase access to medicines. In its judgment in the didanosine patent case against Bristol-Myers Squibb, 1 the Thai Central Intellectual Property and International Trade Court ruled that, because pharmaceutical patents can lead to high prices and limit access to medicines, patients are injured by them and can challenge...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Addiction
سال: 1995
ISSN: 0965-2140
DOI: 10.1111/j.1360-0443.1995.tb03511.x